Vaxcyte (PCVX): Officer filed to sell ~$1.15M

~$1.15M

planned to sell · 17K shares, around Nov 11, 2026

Planned for

Nov 11, 2026

Notice filed

Nov 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$128K)
2. Oct 5, 2026Insider · 2 peopleInsiders: 2 sales (~$3.2M)
3. Oct 6, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
4. Nov 2, 2026Insider · 2 peopleInsiders: 4 sales (~$320K)
5. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
6. Nov 6, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 9.6%
7. Nov 6, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 11.6%
8. Nov 11, 2026Insider · 1 personInsiders: 3 sales (~$1.2M)

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Vaxcyte

For Vaxcyte, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PCVX page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Vaxcyte

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 4, 2026
• SEC Form 4Nov 4, 2026
• SEC Form 4Nov 4, 2026

Everything OQRO holds on this company is on its PCVX page.